Currently available research has reported that LAMC2 and EGFR expressions are positively correlated in bladder cancer, oral (squamous) carcinoma, cholangiocarcionma, as well as in several human cancer cell lines including breast, neoplastic, and ATC cell lines [11, 14–16]. Here, LAMC2 is linked to urinary bladder cancer.